| 2-APB | 2-Aminoethoxydiphenyl borate |
| 20-GPPD | 20-O-β-d-glucopyranosyl-20(S)-protopanaxadiol |
| 5-Fu | 5-Fluorouracil |
| ADMR | adriamycin resistant |
| AITC | allyl isothiocyanate |
| AKT | protein kinase B |
| ALA | α-lipoic acid |
| AMPK | AMP-activated protein kinase |
| AR | androgen receptor |
| AS | astrocytoma |
| ATRA | all-trans retinoic acid |
| BC | breast cancer |
| BKCa | large-conductance voltage-and Ca2+activated K+channel |
| CBD | cannabidiol |
| CBG | cannabigerol |
| ccRCC | clear cell renal cell carcinoma |
| CHOP | CCAAT-enhancer-binding protein homologous protein |
| CPS | capsaicin |
| CPZ | capsazepine |
| CRC | colorectal cancer |
| CSC | cancer stem cell |
| DBZ | dacarbazine |
| DC | dendritic cell |
| DTX | docetaxel |
| EA | Englerin A |
| EGF | epidermal growth factor |
| EMT | epithelial mesenchymal transition |
| ERK | extracellular signal–regulated kinases |
| EV | extracellular vessicle |
| GaC | gastric cancer |
| GBM | glioblastoma |
| GSK-3β | glycogen synthase kinase-3β |
| HCC | hepatocellular carcinoma |
| HIF-1α | hypoxia Inducible Factor 1α |
| IP3LCV | inositol triphosphateleucovorin |
| ME | melanoma |
| MEL | melatonin |
| miRNA | microribonucleic acid |
| MM | multiple myeloma |
| MMP-9 | matrix metalloproteinase-9 |
| MITF | microphthalmia-associated transcription factor |
| NFATc3 | nuclear factor of activated T-cells 3 |
| NSCLC | non-small cell lung cancer |
| OC | ovarian carcinoma |
| OS | overall survival |
| OSCC | eosophageal carcinoma |
| OSC | oral squamous carcinoma |
| PARP-1 | poly (ADP-ribose) polymerase-1 |
| PC | pancreatic cancer |
| PCa | prostate cancer |
| PG | prostaglandin |
| P-gp | P-glycoprotein |
| PI3K | phosphatidylinositole–3-kinase |
| PKC | protein kinase C |
| PSA | prostate-specific antigen |
| RACK1 | receptor of activated protein C kinase 1 |
| RCC | renal cell carcinoma |
| RES | resveratrol |
| ROS | reactive oxigen species |
| Se | selenium |
| SSC | synovial sarcoma cell |
| SOCC | store operated calcium channels |
| SOCE | store-operated calcium entry |
| TNBC | triple-negative breast cancer |
| TRP | transient potential receptor |
| TRPA | transient potential receptor ankyrin |
| TRPC | transient potential receptor canonical |
| TRPM | transient potential receptor melastatin |
| TRPML | transient potential receptor mucolipidin |
| TRPP | transient potential receptor polycystic |
| TRPV | transient potential receptor vanilloid |
| TZL | tonantzitlolone |
| Vac | vacquinol-1 |
| VHL | von Hippel-Lindau |
| WA | waixenicin A |